Raymond Liang

3.0k total citations
50 papers, 1.8k citations indexed

About

Raymond Liang is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Raymond Liang has authored 50 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Hematology and 14 papers in Oncology. Recurrent topics in Raymond Liang's work include FOXO transcription factor regulation (12 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Erythrocyte Function and Pathophysiology (9 papers). Raymond Liang is often cited by papers focused on FOXO transcription factor regulation (12 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Erythrocyte Function and Pathophysiology (9 papers). Raymond Liang collaborates with scholars based in United States, China and Hong Kong. Raymond Liang's co-authors include Saghi Ghaffari, Carolina L. Bigarella, Pauline Rimmelé, Dmitri Papatsenko, Carlo Brugnara, Vivian Chan, Kit-Fai Wong, Yok‐Lam Kwong, Vijay Menon and Yok‐Lam Kwong and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Raymond Liang

47 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raymond Liang United States 20 937 354 275 263 245 50 1.8k
Courtney T. Griffin United States 22 1.0k 1.1× 333 0.9× 168 0.6× 213 0.8× 175 0.7× 50 2.0k
Tsuyoshi Fukushima Japan 26 820 0.9× 213 0.6× 286 1.0× 151 0.6× 338 1.4× 117 2.1k
Kazumi Suzukawa Japan 24 705 0.8× 606 1.7× 203 0.7× 188 0.7× 233 1.0× 75 1.6k
Takashi Sonoki Japan 18 649 0.7× 253 0.7× 265 1.0× 261 1.0× 342 1.4× 98 1.6k
Evgenia Pak United States 23 2.4k 2.5× 205 0.6× 266 1.0× 307 1.2× 331 1.4× 42 3.3k
Fangming Lin United States 21 1.8k 2.0× 269 0.8× 387 1.4× 241 0.9× 214 0.9× 36 3.1k
Eugene Y. Koh United States 18 847 0.9× 232 0.7× 191 0.7× 186 0.7× 509 2.1× 68 1.8k
Soichi Sano Japan 19 1.2k 1.3× 565 1.6× 381 1.4× 108 0.4× 263 1.1× 52 2.3k
Dana E. Cullen United States 11 1.5k 1.6× 751 2.1× 465 1.7× 155 0.6× 329 1.3× 15 2.2k
Marina R. Carpinelli Australia 15 855 0.9× 484 1.4× 265 1.0× 78 0.3× 249 1.0× 30 1.5k

Countries citing papers authored by Raymond Liang

Since Specialization
Citations

This map shows the geographic impact of Raymond Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Liang more than expected).

Fields of papers citing papers by Raymond Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Liang. The network helps show where Raymond Liang may publish in the future.

Co-authorship network of co-authors of Raymond Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond Liang. A scholar is included among the top collaborators of Raymond Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond Liang. Raymond Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Raymond, Lin Miao, Vijay Menon, et al.. (2023). Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis. Blood Advances. 7(22). 6873–6885. 4 indexed citations
2.
Liang, Raymond, Vijay Menon, Jiajing Qiu, et al.. (2021). Mitochondrial localization and moderated activity are key to murine erythroid enucleation. Blood Advances. 5(10). 2490–2504. 18 indexed citations
3.
Liang, Raymond, et al.. (2020). FLT3-CD3 Bispecific Antibody Specifically Eliminates Normal Hematopoietic Progenitors and AML in Humanized Mouse Models. Blood. 136(Supplement 1). 20–21. 2 indexed citations
4.
Arif, Tasleem, et al.. (2019). Lysosomal Activation Is Required for Priming of Quiescent Hematopoietic Stem Cells. Blood. 134(Supplement_1). 722–722.
5.
Liang, Raymond & Saghi Ghaffari. (2018). Stem Cells Seen Through the FOXO Lens: An Evolving Paradigm. Current topics in developmental biology. 127. 23–47. 35 indexed citations
6.
Liang, Raymond, Vijay Menon, & Saghi Ghaffari. (2018). Following Transcriptome to Uncover FOXO Biological Functions. Methods in molecular biology. 1890. 219–227. 4 indexed citations
7.
Liang, Raymond & Saghi Ghaffari. (2017). Mitochondria and FOXO3 in stem cell homeostasis, a window into hematopoietic stem cell fate determination. Journal of Bioenergetics and Biomembranes. 49(4). 343–346. 22 indexed citations
8.
Liang, Raymond & Saghi Ghaffari. (2017). Mitochondria are implicated in the regulation of terminal erythropoiesis. Experimental Hematology. 53. S83–S83. 1 indexed citations
9.
Bigarella, Carolina L., Jianfeng Li, Pauline Rimmelé, et al.. (2016). FOXO3 Transcription Factor Is Essential for Protecting Hematopoietic Stem and Progenitor Cells from Oxidative DNA Damage. Journal of Biological Chemistry. 292(7). 3005–3015. 52 indexed citations
10.
Liang, Raymond, Genís Campreciós, Yan Kou, et al.. (2015). A Systems Approach Identifies Essential FOXO3 Functions at Key Steps of Terminal Erythropoiesis. PLoS Genetics. 11(10). e1005526–e1005526. 52 indexed citations
11.
Zhang, Xin, Genís Campreciós, Pauline Rimmelé, et al.. (2014). FOXO3‐mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis. American Journal of Hematology. 89(10). 954–963. 71 indexed citations
12.
Liang, Raymond & Saghi Ghaffari. (2013). Stem Cells, Redox Signaling, and Stem Cell Aging. Antioxidants and Redox Signaling. 20(12). 1902–1916. 80 indexed citations
13.
Liang, Raymond, et al.. (2009). Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells. Leukemia & lymphoma. 51(3). 515–522. 13 indexed citations
14.
Chim, Chor Sang, et al.. (2007). Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma. Journal of Clinical Pathology. 60(6). 664–669. 31 indexed citations
15.
Cheung, Alice M.S., et al.. (2006). Stem Cell Model of Hematopoiesis. Current Stem Cell Research & Therapy. 1(3). 305–315. 6 indexed citations
16.
Mauch, Peter, Andrea K. Ng, Berthe M.P. Aleman, et al.. (2005). Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long‐term survivors of Hodgkin's disease: July 9–16, 2003, Bellagio, Italy. European Journal Of Haematology. 75(s66). 68–76. 39 indexed citations
17.
Liang, Raymond, D. Todd, T. K. Chan, et al.. (1995). Prognostic factors for primary gastrointestinal lymphoma. Hematological Oncology. 13(3). 153–163. 57 indexed citations
18.
Liang, Raymond, TK Chan, Joyce Chan, et al.. (1995). Intensive consolidation chemotherapy for newly diagnosed acute myeloid leukemia using a regime containing moderate dose cytosine arabinoside and mitoxantrone. Anti-Cancer Drugs. 6(2). 224–228. 2 indexed citations
19.
Liang, Raymond, Edmond Chiu, T. K. Chan, & D. Todd. (1990). Induction chemotherapy for newly diagnosed acute myeloid leukaemia using a regime containing cytosine arabinoside, daunorubicin and etoposide. Cancer Chemotherapy and Pharmacology. 26(5). 380–382. 3 indexed citations
20.
Liang, Raymond, D. Todd, T. K. Chan, et al.. (1988). Follicular non‐Hodgkin's lymphoma in Hong Kong Chinese: A retrospective analysis. Hematological Oncology. 6(1). 29–37. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Courtney T. Griffin Breakdown of academic impact, for papers by Tsuyoshi Fukushima Breakdown of academic impact, for papers by Kazumi Suzukawa Breakdown of academic impact, for papers by Takashi Sonoki Breakdown of academic impact, for papers by Evgenia Pak Breakdown of academic impact, for papers by Fangming Lin Breakdown of academic impact, for papers by Eugene Y. Koh Breakdown of academic impact, for papers by Soichi Sano Breakdown of academic impact, for papers by Dana E. Cullen Breakdown of academic impact, for papers by Marina R. Carpinelli
Rankless by CCL
2026